A Closer Look at 5 Analyst Recommendations For Stoke Therapeutics
A Closer Look at 5 Analyst Recommendations For Stoke Therapeutics
分析師對stoke therapeutics的5個推薦進行更詳細的研究
Ratings for Stoke Therapeutics (NASDAQ:STOK) were provided by 5 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
在過去的三個月中，Stoke Therapeutics(NASDAQ:STOK)的評級由5位分析師提供，展示出看漲和看跌的觀點混合。
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
下表提供了他們最近評級的精簡視圖，顯示了過去30天的不同情緒，並將其與前幾個月進行比較。
Analysts have set 12-month price targets for Stoke Therapeutics, revealing an average target of $24.2, a high estimate of $35.00, and a low estimate of $20.00. Experiencing a 3.2% decline, the current average is now lower than the previous average price target of $25.00.
分析師爲Stoke Therapeutics設定了12個月的價位目標，顯示出平均目標爲24.2美元，最高估計爲35.00美元，最低估計爲20美元。當前平均價位下降了3.2%，現在低於之前的平均價位目標25.00美元。
Understanding Analyst Ratings: A Comprehensive Breakdown
分析師評級：全面解析
A clear picture of Stoke Therapeutics...
通過對最近分...
登入免費觀看全文
登入/註冊